Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$15.22 +0.47 (+3.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ultragenyx Pharmaceutical (RARE) Other Accumulated Expenses (2013 - 2026)

Updated

Ultragenyx Pharmaceutical (RARE) recorded Other Accumulated Expenses of $21 million in Q2 2026, up 0.7% from $20.86 million a year earlier but down 4.5% from the prior quarter.

Analysis

Ultragenyx Pharmaceutical (RARE) Other Accumulated Expenses (2013 - 2026) Analysis & Trends

At the end of FY2025, Ultragenyx Pharmaceutical reported Other Accumulated Expenses of $29 million, up 45.0% from FY2024.

  • Annual Other Accumulated Expenses has a five-year compound annual growth rate of 3.5% (FY2020 to FY2025).
  • Across earlier years, Other Accumulated Expenses came in at $20 million in FY2024 (-35.9%), $31.2 million in FY2023 (-40.2%), $52.18 million in FY2022 (+24.0%) and $42.08 million in FY2021 (+72.2%).
  • Quarterly Other Accumulated Expenses has ranged from $18.95 million in Q3 2025 to $59.93 million in Q3 2022 over the past five years.
  • On a year-over-year basis, Other Accumulated Expenses has increased for three consecutive quarters, with an average decline of 18.5% over the last eight quarters.
  • Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 102.9% in Q2 2022, against a decline of 59.1% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $22 million (Q1 2026), $29 million (Q4 2025) and $18.95 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Ultragenyx Pharmaceutical 1.50 Bn -302.56 Mn 180.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.00 Mn
Mar 31, 2026 22.00 Mn
Dec 31, 2025 29.00 Mn
Sep 30, 2025 18.95 Mn
Jun 30, 2025 20.86 Mn
Mar 31, 2025 20.55 Mn
Dec 31, 2024 20.00 Mn
Sep 30, 2024 29.42 Mn
Jun 30, 2024 29.07 Mn
Mar 31, 2024 50.21 Mn
Dec 31, 2023 31.20 Mn
Sep 30, 2023 50.80 Mn
Jun 30, 2023 51.86 Mn
Mar 31, 2023 45.88 Mn
Dec 31, 2022 52.18 Mn
Sep 30, 2022 59.93 Mn
Jun 30, 2022 54.70 Mn
Mar 31, 2022 44.63 Mn
Dec 31, 2021 42.08 Mn
Sep 30, 2021 32.24 Mn
API Access

Ultragenyx Pharmaceutical Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RARE&period=max&api_key=YOUR_API_KEY